Albert has dedicated himself to novel imaging technologies over two decades. The hands-on experience in biomedical research on top of his education in pharmacy and medical physics brought him to the vision to "Set New Horizons for Clinical Trial Imaging". It is being carried out by transforming tWAN Biotech from an imaging service company into an Imaging CRO serving drug and medical device developers. He has the conviction that Cloud Computing is revolutionizing the marketplaces of drug/device development and shaping the landscape of Medical IoTs as well. Key Activities:2016 Deployed Imaging CRO operation to the cloud platform for clinical trial imaging services.2013 forged the 1st Imaging CRO in Taiwan that provides BICR, Blinded Independent Central Reviewing# Dealing with Site vs Central Discordance of Imaging-based Endpoints # Implementing Practice Guidance for immune-related Criteria, iRECIST, irRECIST & iRC, for Oncology Immunotherapeutics# Handling Imaging Biomarkers, Imaging-based Primary & Surrogate Endpoints and Quantitative Imaging========================================================================Service Designed: Imaging Core Lab for Oncology, CNS and MSK Clinical Trials, Contract ResearchFocused Technology: Quantitative Imaging/Imaging Biomarkers with MRI & CTFocused Application(s): Assessment of Tumor Response to Treatments, esp. Immuno- & Targeted TherapeuticsProducts Represented: MIStar & mint LesionCompany Website: https://www.twan-biotech.com